Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Mercadolibre Inc (MELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Mercadolibre Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Mercadolibre Inc trades at $1,832.26 (market cap $95.11B). The key difference: Mercadolibre Inc is far larger — about 11.2× Hinge Health Inc. Class A Common Stock's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Hinge Health Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Mercadolibre Inc for 118 Days on average.
| HNGE | MELI | |
|---|---|---|
Market Cap | $8.48B | $95.11B |
Volume | 879,799 | 242,115 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $2.36K |
52-Week Low | $31.17 | $1.55K |
Typical Hold Time | 0 Days | 118 Days |
Enterprise Value | $8.10B | $102.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
MercadoLibre (MELI) trades at $1,839.11, down 2.82% on the day, amid a bullish technical setup and strong analyst support. The stock shows robust revenue growth, with 2025 sales reaching $28.89 billion, though net income margins have softened. Recent news highlights expansion in Brazil, including one-hour delivery and pharmacy services, while its fintech credit portfolio surged 75% in Q2 2026.
Outlook remains positive given dominant Latin American e-commerce and fintech positioning, but risks include macroeconomic pressures in key markets like Argentina and elevated valuation multiples. Wall Street consensus is strongly bullish with a $2,160 price target, though profit trends warrant monitoring for sustained shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →
